Picard Medical, Inc. (PMI) - Total Liabilities
Based on the latest financial reports, Picard Medical, Inc. (PMI) has total liabilities worth $18.76 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Picard Medical, Inc. to evaluate the company's liquid asset resilience ratio.
Picard Medical, Inc. - Total Liabilities Trend (2022–2025)
This chart illustrates how Picard Medical, Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Picard Medical, Inc.'s balance sheet.
Picard Medical, Inc. Competitors by Total Liabilities
The table below lists competitors of Picard Medical, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Agat Ejendomme A/S
CO:AGAT
|
Denmark | Dkr502.00 Million |
|
Asia Seed Co.Ltd
KQ:154030
|
Korea | ₩16.44 Billion |
|
Toleranzia AB
ST:TOL
|
Sweden | Skr9.54 Million |
|
Minbos Resources Ltd
AU:MNB
|
Australia | AU$2.11 Million |
|
Bionano Genomics Inc
NASDAQ:BNGO
|
USA | $15.98 Million |
|
Wahana Pronatural
JK:WAPO
|
Indonesia | Rp98.34 Billion |
|
Soditech SA
PA:SEC
|
France | €4.43 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Picard Medical, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Picard Medical, Inc.'s balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.83 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Picard Medical, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Picard Medical, Inc. (2022–2025)
The table below shows the annual total liabilities of Picard Medical, Inc. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $18.76 Million | -47.66% |
| 2024-12-31 | $35.84 Million | +140.13% |
| 2023-12-31 | $14.93 Million | +266.64% |
| 2022-12-31 | $4.07 Million | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more